Dr. Demetri is director of Dr. Demetri is director of the Sarcoma Center at Dana-Farber, director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, and executive director for Clinical and Translational Research at the Ludwig Institute for Cancer Research.
George Demetri, M.D., is a George D. Demetri, M.D. Dr. Demetri currently serves at the Quick Family Chair in Medical Oncology and Director of the Sarcoma Center at Dana-Farber Cancer Institute, as well as Professor of Medicine at Harvard Medical School and Co-Director of the Ludwig Center at Harvard.
George D. Demetri, MD, In addition to serving as the co-director of the Ludwig Center, he is an associate director for clinical sciences at the Dana-Farber/Harvard Cancer Center, the NCI-designated comprehensive cancer center of Harvard University.
In addition to serving as Professor of Medicine, Harvard Medical School; Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute George Demetri, M.D., is a physician scientist with a translational and clinical career that has led to the development of rationally targeted anti-cancer therapeutics.
Demetri is a leader in George Demetri, MD, director of the Sarcoma Center at Dana-Farber Cancer Institute, is being awarded the prestigious J.E. Wallace Sterling Lifetime Achievement Award in Medicine from the Stanford Medicine Alumni Association (SMAA).
In this video, George Demetri, Our group is translating this research on the basic biology of sarcomas into new therapeutics directed at novel targets. The foremost example of our team's work has been the development of tyrosine kinase inhibitors as effective therapies for patients with gastrointestinal stromal tumor (GIST).
George Daniel Demetri, MD, Title: Professor As director of the Center for Sarcoma and Bone Oncology and now the senior vice president for Experimental Therapeutics at the Dana-Farber Cancer Institute, George Demetri, MD, has long been a leader in treating complex cancers.
Dr. Demetri received his undergraduate
In addition to leading Dana-Farber’s Sarcoma program, Demetri also serves as Senior Vice President for Experimental Therapeutics at Dana-Farber, the Quick Family Chair in Medical Oncology at Dana-Farber and is a Professor of Medicine at Harvard Medical School. He is one of 25 new fellows elected to the AACR Academy.